27 Year1Target groupPopulationReachScreeningNumber of TB Patient60% M+ (estimated)questionaireCXRGeneXpertMigrant271,665108,666Not done10,867869.3521.6Prisoner136,54195,5799,558764.6458.8Elderly DM49,00012,250257.3-TB among HIV120,56496,45124,1134,822.62,893.5Contact SM+90,43627,1312,713108.565.1Contact MDR2,693107.764.6Total670,898379,51951,69362,1936,9304,004Year2135,83313,5831,086.7652.0109,23310,923873.9524.351,45012,863270.1150,899120,71930,1806,035.93,621.694,88633,2103,321132.879.73,189127.676.5708,630453,63354,63974,0598,5274,954YearLPANumber of MDR-TBSLDSTMDR suspected18,99215,1943,744539year223,15018,5204,491638
28 The JIMM identified the following key issues that NSP (2015-2019) addresses 1. Low case notifications2. Inefficient reporting and surveillance systems3. Urgent need for improvement of treatment outcomes4. Provision of suitable care for all migrants in need
29 Modules and key interventions Modules 9: TB care and preventionKey interventionsEarly case detection and ICF focusing on high risk MWs, prisoners, elderly, MDR and HIV-TB patientsIntensified DOTsIPT for contacts of child TBContact tracing of all M+, MDR and elderly M+ casesDevelopment of TBCM to ensure complete case notification and PPM activitiesTreatment provision for uninsured migrants and prisonersRapid diagnosis using rapid molecular diagnostic tools
30 Modules and key interventions Modules 10: TB-HIVKey interventionsImplementati on of TB-HIV collaborative activities at national and sub-national levels including, HIV testing of TB patientsTB screening in HIV patientsIPT for HIV patients with TB contacts, coordinating body for HIV-TBIntensified DOTsEarly initiation of ART in co-infection patients
31 Modules and key interventions Modules 11: MDR TBKey interventionsEarly case detection using rapid molecular diagnostics in decentralized settingsProvision of second- line treatment for uninsured MDR TB patientslab monitoring; infection control; coordination of ART for patients with HIV.Including social and living support; DOT for all patientsCoordination of ART for patients with HIV.
32 Reach Recruit Retain Test Treat BTBReachRecruitRetainTestTreatModule 9 MDR-TBMDR TB-1: Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)MDR TB-2: Number of bacteriologically confirmed, drug resistant TB cases (RR-TB and/or MDR-TB) notifiedMDR TB-3: Number of cases with drug resistant TB (RR-TB and/or MDR-TB) that began second-line treatmentModule 10 TB care and preventionDOTS-1a: Number of notified cases of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapsesDOTS-2a: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all new TB cases registered for treatment during a specified periodDOTS-6: Number of TB cases (all forms) notified among key affected populations/high risk groupsModule 11 TB/HIVTB/HIV-1: Percentage of TB patients who had an HIV test result recorded in the TB registerTB/HIV-2: Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatmentTB/HIV-3: Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settingsTB/HIV-4: Percentage of new HIV-positive patients starting IPT during the reporting periodModule 12 HSS - Health information systems and M&EM&E-1: Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines